CAT and prostate carcinoma: In vivo studies using zebrafish and mouse xenograft models further validated its anti-prostate cancer efficacy.<h4>Conclusion</h4>Trichodermamide B targets catalase while mediating crosstalk between the catalase axis and the AR signalling axis to induce oxidative stress and apoptosis in prostate cancer cells.